I believe board seats and lead investor/pro-rata rights are just negotiation terms and not a must for a Series A. Your other point is a good one. If there was

I believe board seats and lead investor/pro-rata rights are just negotiation terms and not a must for a Series A. Your other point is a good one. If there was no valuation and only convertible notes were issues, then I understand why this would not be a Series A.